focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Finance Director sells 43,000 shares

Wed, 14th Mar 2012 15:32

John Worby, Group Finance Director of Genus, the FTSE 250 animal genetics firm, has sold 43,000 shares, half of the amount he vested earlier this month. Worby sold 43,261 shares at 1,318.41p each for a total of £570,357. The sale was made further to the vesting of 86,523 conditional nil-cost share options on March 5th under the company's performance share plan. The remaining 43,262 share options that vested under the plan have been retained by Worby. Towards the end of last month the firm reported strong growth in sales volumes in Asia has seen animal genetics firm Genus increase revenue by almost a 10th in the first half of its financial year.Furthermore, after reviewing its dividend policy last year, the firm has decided to start paying an interim dividend for the first time this year. The board has approved an interim dividend of 4.5p per share payable on March 30th. The stock has rocketed in the past past year, rising almost 44%, equivalent to 404p. The share price is up 0.84%, or 11p over the past week. Top Director BuysCapital Shopping Centres Group (CSCG) Director name: Mr John Whittaker Amount purchased: 300,000 @ 347.24p Value: £1,041,720Capital Shopping Centres Group (CSCG) Director name: Mr John Whittaker Amount purchased: 300,000 @ 344.55p Value: £1,033,650FBD Holdings (FBH) Director name: Mr Andrew LangfordAmount purchased: 6,818 @ € 9.03 Value: € 61,567Cello Group (CLL) Director name: Mr Mark ScottAmount purchased: 60,500 @ 41.00p Value: £24,805Marks & Spencer Group (MKS) Director name: Ms Miranda CurtisAmount purchased: 5,500 @ 367.50p Value: £20,212BG Group (BG.) Director name: Mr Caio Koch-WeserAmount purchased: 1,000 @ 1,533.14p Value: £15,331BG Group (BG.) Director name: Mr Caio Koch-WeserAmount purchased: 700 @ 1,535.23p Value: £10,747Top Director SellsRolls-Royce Holdings (RR.) Director name: Mr Mike TerrettAmount sold: 287,997 @ 818.25p Value: £2,356,535Barclays (BARC) Director name: Mr Chris LucasAmount sold: 613,536 @ 239.88p Value: £1,471,750Rolls-Royce Holdings (RR.) Director name: Mr Colin P SmithAmount sold: 175,690 @ 818.25p Value: £1,437,583Rolls-Royce Holdings (RR.) Director name: Mr James M GuyetteAmount sold: 113,484 @ 818.25p Value: £928,583Genus (GNS) Director name: Mr John WorbyAmount sold: 43,261 @ 1,318.41p Value: £570,357Sage Group (SGE) Director name: Mr Guy BerruyerAmount sold: 113,925 @ 297.97p Value: £339,462Sage Group (SGE) Director name: Mr Guy BerruyerAmount sold: 105,026 @ 300.00p Value: £315,078Sage Group (SGE) Director name: Mr David ClaytonAmount sold: 72,958 @ 297.97p Value: £217,393Sage Group (SGE) Director name: Mr Paul HarrisonAmount sold: 72,660 @ 297.97p Value: £216,505Rolls-Royce Holdings (RR.) Director name: Mr Mark MorrisAmount sold: 24,846 @ 818.25p Value: £203,302
More News
18 Sep 2019 11:20

Cello Health reports positive momentum as it works on US market

(Sharecast News) - Healthcare-focussed advisory firm Cello Health reported a 6.8% improvement in net revenue to £54.5m in its half-year results on Wednesday, with its like-for-like constant currency net revenue growth standing at 4.5%.

Read more
18 Sep 2019 11:09

Cello Health Interim Profit Rises Sharply On Unit Performance

(Alliance News) - Cello Health PLC on Wednesday posted a markedly increased profit for the first half of 2019, pushed up by its Cello Health division.Shares in Cello were up 2.4% at 126.00

Read more
16 Aug 2019 10:45

Cello Health Acquires Innovative Science Solutions For USD11 Million

(Alliance News) - Healthcare advisory group Cello Health PLC said Friday it will acquire Innovative Science Solutions for up to USD10.5 million.ISS is a scientific consulting firm focused a

Read more
16 Aug 2019 07:57

Cello Health buys US-based scientific consulting firm ISS

(Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.

Read more
18 Jul 2019 11:00

Cello Health Expects Like-For-Like Revenue Growth From First Half

(Alliance News) - Healthcare-focused advisory firm Cello Health PLC said on Thursday that it had a strong first half of the year, expecting like-for-like growth in net revenue and headline pretax

Read more
8 May 2019 10:38

Cello Health Expects Annual Result In Line Amid "Very Good" 2019 Start

LONDON (Alliance News) - The chair of healthcare advisory firm Cello Health PLC said Wednesday it expects its full-year results in line with expectations after a "very good" start to at

Read more
8 May 2019 10:37

Cello Health revenues and headline profits grow in Q1

(Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.

Read more
27 Mar 2019 14:04

FIL Lowers Cello Health Stake To Below 5% Notifiable Threshold (ALLISS)

LONDON (Alliance News) - Cello Health PLC on Wednesday said that FIL Ltd reduced its interest in the company to below the 5% notifiable threshold.Prior to Tuesday's deal, FIL held a in

Read more
21 Mar 2019 10:16

Cello Health Boosts Dividend As Lower Costs Lead To Profit Rise

LONDON (Alliance News) - Cello Health PLC on Thursday said its profit increased in 2018 due to a reduction in third party contract costs, while it has also hiked its dividend.Revenue for in

Read more
17 Jan 2019 13:21

Cello Health Trading In Line With Views Though Signal Business Slows

LONDON (Alliance News) - Cello Health PLC on Thursday said it is expecting results in line with market expectations despite slower client activity in the Cello Signal business.The marketing

Read more
17 Jan 2019 10:44

Cello Health sees strong like-for-like growth in 2018

(Sharecast News) - Healthcare-led advisory group Cello Health updated the market for the year ended 31 December on Thursday, reporting that it traded "well" in 2018, with continued strong like-for-like growth from Cello Health somewhat offset by a slower outcome from Cello Signal.

Read more
5 Nov 2018 14:35

Cello Health Promotes Director Chris Jones To Non-Executive Chairman

LONDON (Alliance News) - Healthcare-focused advisory group Cello Health PLC said Monday it has promoted Chris Jones to non-executive chairman with immediate effect, following the retirement of a a

Read more
10 Oct 2018 12:39

DIRECTOR DEALINGS: Cello Health Non-Executive Buys GBP30,000 In Shares

LONDON (Alliance News) - Cello Health PLC said Wednesday that Non-Executive Director Chris Jones bought shares in the company worth GBP29,998 worth of shares.Jones acquired 22,726 shares at

Read more
2 Oct 2018 11:11

Cello Health Promotes US Division CEO Ralston As Executive Director

LONDON (Alliance News) - Cello Health PLC said Tuesday it promoted Julia Ralston as executive director of the company with immediate effect.Ralston is currently the chief executive officer

Read more
19 Sep 2018 10:11

Cello Health Plans Expansion In US As Profit Increases In First-Half

LONDON (Alliance News) - Cello Health PLC on Wednesday said it plans further investments in developing its US business following profit growth in the first half of 2018.The advisory firm to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.